# Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD

> **NCT03388385** · PHASE4 · UNKNOWN · sponsor: **Carol Davila University of Medicine and Pharmacy** · enrollment: 40 (actual)

## Conditions studied

- Renal Anemia
- Iron Toxicity
- Oxidative Stress
- Endothelial Dysfunction

## Interventions

- **DRUG:** Sodium Chloride 0.9% Intravenous Solution
- **DRUG:** Ferinject

## Key facts

- **NCT ID:** NCT03388385
- **Lead sponsor:** Carol Davila University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-20
- **Primary completion:** 2020-12-30
- **Final completion:** 2022-12-20
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388385, "Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03388385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*